Questions about Kelly Labs
What is Kelly Labs?
Kelly Labs provides assay development services for drug discovery, partnering with biotech and pharmaceutical firms across rare disease, CNS, oncology, and immunology. They build, optimize, miniaturize, and automate assay platforms on-site in clients' laboratories using the client's own equipment and cells without requiring tech transfer. Services span feasibility and research through hit identification and validation, including remote consultation and CRO management.
What therapeutic modalities and assay types does Kelly Labs support?
The company works on small molecules and oligonucleotide therapeutics, designing both in vitro and in vivo assays that connect findings to PK/PD relationships. They apply cellular and biochemical platforms to assess various endpoints and interrogate relevant biology in disease models chosen specifically for the target and biology at hand.
What are the core goals and quality standards for Kelly Labs' assays?
Kelly Labs builds translational pipelines that connect in vitro findings to PK/PD relationships in vivo, ensuring assays are biologically relevant, sensitive enough to identify and rank active compounds, robust, statistically valid, and feasible to run at scale.
What specific discovery stage services and throughput levels does Kelly Labs offer?
The business covers the discovery stage from feasibility and research through hit ID and validation, offering low to high throughput support with capabilities to enable automation. They design assays that assess a variety of endpoints and apply them to interrogate the relevant biology in disease models chosen specifically for the target and biology at hand.
How does Kelly Labs structure its operational model for clients?
Kelly Labs operates as an in-person/on-site CRO that comes to the client's lab, building assays directly using the client's existing infrastructure to eliminate tech transfer delays. They also provide virtual consultation and CRO management for remote strategic support, including assay design, troubleshooting, and data interpretation delivered remotely.
What are the six specific capability areas Kelly Labs provides?
The company offers six capability areas that can be applied together or independently: Assay Development & Automation, Cellular & Biochemical Platforms, Target Engagement & Validation, Phenotypic Assessment & Pathway Modulation, In Vitro/In Vivo Disease Models, and PK/PD Translational Pipelines.
How does Kelly Labs handle assay execution and client training?
The business trains client scientists to run assays independently or returns periodically to run them on whatever cadence the program needs. They offer remote strategic support for teams that need expert input without adding headcount, covering program strategy across lead discovery and target validation.
What specific tools and techniques does Kelly Labs use for assay development?
The company builds, optimizes, and miniaturizes assay platforms using a broad toolkit of cellular models and biochemical techniques matched to the client's platform. They ensure compound specificity and engagement while building assays that capture functional, phenotypic endpoints.
How can I contact Kelly Labs?
You can reach Kelly Labs by e-mail at hello@kellylabs.bio.
What is the official website of Kelly Labs?
The official website of Kelly Labs is kellylabs.bio.
Does Kelly Labs have reviews on Trustburn?
Kelly Labs has no reviews on Trustburn yet. Anyone who has used it can write the first review on its Trustburn page.
AI-generated from reviews on this page. Verify anything important with the company directly.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About Kelly Labs
Kelly Labs provides assay development services for drug discovery. The company partners with biotech and pharmaceutical firms across disease areas such as rare disease, CNS, oncology, and immunology, working on small molecules and oligonucleotide therapeutics. It builds, optimizes, miniaturizes, and automates assay platforms on-site in clients' laboratories, using their equipment and cells, without requiring tech transfer. Services span feasibility and research through hit identification and validation, and include remote consultation and CRO management. The company designs in vitro and in vivo assays that connect findings to PK/PD relationships and applies cellular and biochemical platforms alongside target engagement approaches.
- Website
- kellylabs.bio
- hello@kellylabs.bio
- Categories
- Pharmaceuticals, Research, Biotechnology